Fingerprint
Dive into the research topics of 'Phase II study of imatinib mesylate in chemotherapy refractory germ cell tumors expressing KIT'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Lawrence H. Einhorn, Mary J. Brames, Michael C. Heinrich, Christopher L. Corless, Ali Madani
Research output: Contribution to journal › Article › peer-review